Abstract:The angiopoietin/Tie-2 system plays an important role in the initiation of angiogenesis. However, the role of angiopoietin/Tie-2 in peritoneal angiogenesis and fibrosis is unclear. In our study we investigated the peritoneal morphologic changes in a uremic peritoneal dialysis (PD) rat model, focusing on the relationship between angiopoietin/Tie-2 and peritoneal angiogenesis. We subjected uremic (subtotal nephrectomy) rats to dialysis, using a standard PD solution, for 10 days, 28 days, or 56 days, and compared them with uremic rats that had not undergone dialysis and control rats. Functional [dialysate-to-plasma (D/P) creatinine; ultrafiltration (UF)] and structural (vessel density and thickness of the submesothelial extracellular matrix) changes of the peritoneum were quantified. Levels of angiopoietin (Ang)-1, Ang-2, Tie-2 and vascular endothelial growth factor (VEGF) were examined in the peritoneum by real-time quantitative polymerase chain reaction (PCR) and related to angiogenesis. The uremic group that had not undergone dialysis was characterized by increased vessel density in the peritoneum compared with that of the control, which correlated with decreased UF and increased D/P creatinine. Progressive angiogenesis and fibrosis were found in the PD groups when compared with the uremic non-dialyzed or control group, accompanied by an increased D/P creatinine that occurred in the PD group after 56 days, while UF decreased. Furthermore, Ang-2 and VEGF levels increased, while Tie-2 level decreased significantly in the uremic non-dialyzed group compare with the control. This tendency was more obvious in the PD groups than in the uremic non-dialyzed or control group, but no difference was found among the PD groups. Both VEGF and Ang-2 correlated positively with vessel density, while Tie-2 correlated negatively. We confirmed angiogenesis and fibrosis changes of the peritoneum as a result of uremic status and PD therapy in the uremic PD rat model. An increased level of Ang-2 and a reduced level of Tie-2 in conditions of uremia and PD therapy correlated with peritoneal angiogenesis and functional deterioration.

WNT Signaling is Required for Peritoneal Membrane Angiogenesis.

Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis

The role of WNT5A and Ror2 in peritoneal membrane injury

Matrix Metalloproteinase 9 is Associated with Peritoneal Membrane Solute Transport and Induces Angiogenesis Through Β-Catenin Signaling.

Novel Long Non-Coding RNA AV310809 Promotes TGF-β1 Induced Epithelial-Mesenchymal Transition of Human Peritoneal Mesothelial Cells Via Activation of the Wnt2/β-catenin Signaling Pathway.

Peritoneal Morphological and Functional Changes Associated with Platelet-Derived Growth Factor B

Beta-Catenin Participates in Dialysate-Induced Peritoneal Fibrosis Via Enhanced Peritoneal Cell Epithelialto-Mesenchymal Transition

Notch Activity is Increased in a Rat Peritoneal Fibrosis Model Induced by High Glucose Dialysate

Autophagy Promotes Fibrosis and Apoptosis in the Peritoneum During Long-Term Peritoneal Dialysis

Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2

New Insights into the Pathogenesis and Treatment of Peritoneal Fibrosis: A Potential Role of Wnt/β-catenin Induced Epithelial to Mesenchymal Transition and Stem Cells for Therapy

Angiotensin II-mediated activation of fibrotic pathways through ERK1/2 in rat peritoneal mesothelial cells.

MicroRNA-302c Modulates Peritoneal Dialysis-Associated Fibrosis by Targeting Connective Tissue Growth Factor

Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis

Wnt/beta-catenin signaling promotes renal interstitial fibrosis.

Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent.

Endothelin-1 triggers human peritoneal mesothelial cells' proliferation via ERK1/2-Ets-1 signaling pathway and contributes to endothelial cell angiogenesis.

Pressure induces peritoneal fibrosis and inflammation through CD44 signaling

The Disruptor of Telomeric Silencing 1-Like (DOT1L) Promotes Peritoneal Fibrosis Through the Upregulation and Activation of Protein Tyrosine Kinases

PI3K/Akt signaling regulates epithelial-mesenchymal transition of peritoneal mesothelial cells in peritoneal dialysis

Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy